Oncostatin M promotes bone formation independently of resorption when signaling through leukemia inhibitory factor receptor in mice

IL-23 Inhibits Osteoclastogenesis Indirectly through Lymphocytes and Is Required for the Maintenance of Bone Mass in Mice

(2014) J. M. W. Quinn et al.   JOURNAL OF IMMUNOLOGY

A Short Treatment With an Antibody to Sclerostin Can Inhibit Bone Loss in an Ongoing Model of Colitis*

(2009) Alison Eddleston et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Osteocytes, mechanosensing and Wnt signaling

(2008) Lynda F. Bonewald et al.   BONE

Role of gp130-mediated signalling pathways in the heart and its impact on potential therapeutic aspects

(2008) P Fischer et al.   BRITISH JOURNAL OF PHARMACOLOGY

Cardiotrophin-1 Is an Osteoclast-Derived Stimulus of Bone Formation Required for Normal Bone Remodeling

(2008) Emma C Walker et al.   JOURNAL OF BONE AND MINERAL RESEARCH

EphrinB2 Regulation by PTH and PTHrP Revealed by Molecular Profiling in Differentiating Osteoblasts

(2008) Elizabeth H Allan et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Sclerostin Antibody Treatment Increases Bone Formation, Bone Mass, and Bone Strength in a Rat Model of Postmenopausal Osteoporosis*

(2008) Xiaodong Li et al.   JOURNAL OF BONE AND MINERAL RESEARCH

gp130 signaling in bone cell biology: Multiple roles revealed by analysis of genetically altered mice

(2008) Natalie A. Sims   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Bone remodeling: Multiple cellular interactions required for coupling of bone formation and resorption

(2008) Natalie A. Sims et al.   SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY